Robert M. Carey

ORCID: 0000-0001-7238-7396
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hormonal Regulation and Hypertension
  • Renin-Angiotensin System Studies
  • Blood Pressure and Hypertension Studies
  • Particle physics theoretical and experimental studies
  • High-Energy Particle Collisions Research
  • Receptor Mechanisms and Signaling
  • Quantum Chromodynamics and Particle Interactions
  • Ion Transport and Channel Regulation
  • Sodium Intake and Health
  • Nitric Oxide and Endothelin Effects
  • Electrolyte and hormonal disorders
  • Adrenal Hormones and Disorders
  • Renal function and acid-base balance
  • Adrenal and Paraganglionic Tumors
  • Apelin-related biomedical research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Neuropeptides and Animal Physiology
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Dark Matter and Cosmic Phenomena
  • Muon and positron interactions and applications
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Neutrino Physics Research
  • Protein Hydrolysis and Bioactive Peptides
  • Birth, Development, and Health

Boston University
2002-2024

University of Virginia Health System
2014-2023

University of Virginia
2013-2023

Flinders Medical Centre
2023

GTx (United States)
2021-2022

University of Southern Denmark
2013-2022

University of Cape Town
2022

Charité - Universitätsmedizin Berlin
2022

Humboldt-Universität zu Berlin
2022

Freie Universität Berlin
2022

To develop clinical practice guidelines for the management of patients with primary aldosteronism.The Task Force included a chair, selected by Clinical Guidelines Subcommittee Endocrine Society, six additional experts, methodologist, and medical writer. The guideline was cosponsored American Heart Association, Association Surgeons, European Society Endocrinology, Hypertension, International Japan Japanese Hypertension. received no corporate funding or remuneration.We searched systematic...

10.1210/jc.2015-4061 article EN cc-by-nc-nd The Journal of Clinical Endocrinology & Metabolism 2016-03-02

Resistant hypertension is a common clinical problem faced by both primary care clinicians and specialists. While the exact prevalence of resistant unknown, trials suggest that it not rare, involving perhaps 20% to 30% study participants. As older age obesity are 2 strongest risk factors for uncontrolled hypertension, incidence will likely increase as population becomes more elderly heavier. The prognosis but cardiovascular undoubtedly increased patients often have history long-standing,...

10.1161/circulationaha.108.189141 article EN Circulation 2008-06-23

Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism.

10.1210/jc.2008-0104 article EN cc-by-nc-nd The Journal of Clinical Endocrinology & Metabolism 2008-06-14

Resistant hypertension is a common clinical problem faced by both primary care clinicians and specialists. While the exact prevalence of resistant unknown, trials suggest that it not rare, involving perhaps 20% to 30% study participants. As older age obesity are 2 strongest risk factors for uncontrolled hypertension, incidence will likely increase as population becomes more elderly heavier. The prognosis but cardiovascular undoubtedly increased patients often have history long-standing,...

10.1161/hypertensionaha.108.189141 article EN Hypertension 2008-04-08

Background: The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Prevention, Detection, Evaluation and Management High Blood Pressure in Adults provides recommendations definition hypertension, systolic diastolic blood pressure (BP) thresholds initiation antihypertensive medication, BP target goals. Objectives: This study sought to determine prevalence implications above treatment goal among US adults using criteria from ACC/AHA guideline Seventh...

10.1161/circulationaha.117.032582 article EN Circulation 2017-11-13

Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes, commonly including long-acting calcium channel blocker, blocker renin-angiotensin system (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker), and diuretic. The drugs should be administered at maximum maximally tolerated daily doses. RH also includes patients whose BP achieves target values on ≥4 medications....

10.1161/hyp.0000000000000084 article EN Hypertension 2018-10-10

10.1016/s2213-8587(17)30135-3 article EN The Lancet Diabetes & Endocrinology 2017-05-31

Since publication of the 1980 Report Joint National Committee on Detection, Evaluation, and Treatment High Blood Pressure,<sup>1</sup>several events have occurred that affect successful management hypertension: major clinical trial results, introduction new antihypertensive agents, evidence concerning effectiveness nonpharmacologic treatment, further analysis epidemiologic data-base relating BPs with risk premature morbidity mortality. These led director Heart, Lung, Institute (NHLBI), as...

10.1001/archinte.1984.00350170211032 article EN Archives of Internal Medicine 1984-05-01

Patchy subcortical foci of increased signal intensity are frequently identified on magnetic resonance imaging (MRI) in the elderly. The incidence and clinical correlates these lesions remain unknown. In this report, 240 consecutive MRI scans performed over a 6-month period were reviewed (excluding patients with recent brain trauma or known demyelinating disease). Subcortical incidental (ILs) identified, which could not be accounted for by patient's current diagnosis, neurological status, CT...

10.1161/01.str.17.6.1084 article EN Stroke 1986-11-01

The angiotensin AT2 receptor modulates renal production of cyclic guanosine 3',5'-monophosphate (cGMP; J. Clin. Invest. 1996. 97:1978-1982). In the present study, we hypothesized that II (Ang II) acts at to stimulate nitric oxide leading previously observed increase in cGMP. Using a microdialysis technique, monitored changes interstitial fluid (RIF) cGMP response intravenous infusion antagonist PD 123319 (PD), AT1 Losartan, synthase (NOS) inhibitor nitro--arginine-methyl-ester (-NAME),...

10.1172/jci119531 article EN Journal of Clinical Investigation 1997-07-15

Description: In November 2017, the American College of Cardiology (ACC) and Heart Association (AHA) released a clinical practice guideline for prevention, detection, evaluation, treatment high blood pressure (BP) in adults. This article summarizes major recommendations. Methods: 2014, ACC AHA appointed multidisciplinary committee to update previous reports Joint National Committee on Prevention, Detection, Evaluation, Treatment High Blood Pressure. The reviewed literature commissioned...

10.7326/m17-3203 article EN cc-by Annals of Internal Medicine 2018-01-22

Primary aldosteronism is a nonsuppressible renin-independent aldosterone production that causes hypertension and cardiovascular disease.To characterize the prevalence of production, as well biochemically overt primary aldosteronism, in relation to blood pressure.Cross-sectional study.4 U.S. academic medical centers.Participants with normotension (n = 289), stage 1 115), 2 203), resistant 408).Participants completed an oral sodium suppression test, regardless or renin levels, confirmatory...

10.7326/m20-0065 article EN Annals of Internal Medicine 2020-05-25
Coming Soon ...